Oligonucleotide
Nusinersen
Own facility · Oligonucleotide
Nusinersen is supplied by BOOKPHARM as an active ingredient in the oligonucleotide area. siRNA and antisense oligonucleotide therapeutics for targeted gene silencing, developed under CDMO programs. Business model: cdmo. Listed status: CDMO.
Supply offerings
| Business line | Business model | Regulatory status |
|---|---|---|
| FDFOligonucleotide | CDMO | CDMO |
Supplied for pharmaceutical manufacturing and R&D by licensed and qualified entities. Not for human use as supplied. Availability is subject to regulatory approval in the buyer's jurisdiction.